Public Interest in Using GLP-1 Drugs for Weight Loss Beyond the share who have used these drugs, much of the public has encountered GLP-1 drugs, with about four in ten (37%) adults saying they have a close friend or family member who is using one to either lose weight or treat a chronic condition
Different investigations may utilize different formulations, dosing approaches, or treatment durations, making it challenging to compare results across studies and establish optimal therapeutic protocols
Kola B, Christ-Crain M, Lolli F, et al
As glucagon-like peptide-1 receptor agonists (GLP-1s) continue to be prescribed by providers, including FDA-approved commercial versions and compounded versions, we routinely are asked for guidance by providers around prescribing compounded drugs
Shame and Stigma Many GLP-1 users carry a private burden: the belief that needing this medicine is proof of something they failed to do on their own
Are vegans the same as B12-deficient